(VIANEWS) – GDL Fund, The (GDL), United Bankshares (UBSI), Royalty Pharma (RPRX) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio as yet. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. GDL Fund, The (GDL)

200% Payout Ratio

GAMCO Investors, Inc. launched the GDL Fund, a closed-ended equity mutual funds. Gabelli Funds, LLC manages it.

Volume

Today’s last reported volume for GDL Fund, The is 1651, 88.17% below its average volume of 13959.

As maintained by Morningstar, Inc., the next dividend payment is on Jun 13, 2022, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 5.79%.

Volatility

GDL Fund, The’s last day, week, and month’s current intraday variation average was 0.36%, 0.29%, and 0.60%, respectively.

GDL Fund, The’s highest amplitude of average volatility was 0.61% (day), 0.44% (last week), and 1.62% (last month), respectively.

GDL Fund, The’s Stock Yearly Top and Bottom Value

GDL Fund, The’s stock is valued at $8.29 at 08:23 EST, way under its 52-week high of $9.26 and higher than its 52-week low of $7.92.

GDL Fund, The’s Moving Average

GDL Fund, The’s worth is above its 50-day moving average of $8.22 and below its 200-day moving average of $8.62.

2. United Bankshares (UBSI)

54.62% Payout Ratio

United Bankshares, Inc. is a financial holding firm that primarily offers commercial and retail banking services and products in the United States.

Volume

Today’s last reported volume for United Bankshares is 2617050, 297.34% above its average volume of 658641.

As stated by Morningstar, Inc., the next dividend payment is on Jun 8, 2022, the estimated forward annual dividend rate is 1.44 and the estimated forward annual dividend yield is 3.72%.

United Bankshares’s sales growth this year is anticipated to be negative 1.5% and 6.8% for next year.

Year-on-year quarterly revenue growth grew by 1%, now sitting on 1B for the twelve trailing months.

United Bankshares’s sales growth is 6.3% for the ongoing quarter and 9.3% for the next. The company’s growth estimates for the present quarter and the next is negative 7% and 17.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.73%.

Volatility

United Bankshares’s last day, week, and month’s current intraday variation average was 1.28%, 1.36%, and 1.08%, respectively.

United Bankshares’s highest amplitude of average volatility was 1.54% (day), 2.08% (last week), and 2.22% (last month), respectively.

United Bankshares’s Stock Yearly Top and Bottom Value

United Bankshares’s stock is valued at $38.74 at 08:23 EST, under its 52-week high of $39.80 and way higher than its 52-week low of $31.74.

United Bankshares’s Moving Average

United Bankshares’s value is above its 50-day moving average of $35.97 and higher than its 200-day moving average of $36.07.

3. Royalty Pharma (RPRX)

48.95% Payout Ratio

Royalty Pharma plc is a purchaser of biopharmaceutical royalty payments and a financier of innovation in the US biopharmaceutical sector.

Volume

Today’s last reported volume for Royalty Pharma is 1255780, 41.11% below its average volume of 2132580.

According to Morningstar, Inc., the next dividend payment is on May 18, 2022, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 1.95%.

Royalty Pharma’s sales growth this year is expected to be negative 1% and 7.8% for next year.

Year-on-year quarterly revenue growth grew by 0.6%, now sitting on 2.29B for the twelve trailing months.

Royalty Pharma’s sales growth is 0.4% for the present quarter and negative 0.5% for the next. The company’s growth estimates for the current quarter and the next is 11.3% and negative -5.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.32%.

Volatility

Royalty Pharma’s last day, week, and month’s current intraday variation average was 1.68%, 0.73%, and 0.70%, respectively.

Royalty Pharma’s highest amplitude of average volatility was 1.99% (day), 2.44% (last week), and 2.03% (last month), respectively.

Royalty Pharma’s Stock Yearly Top and Bottom Value

Royalty Pharma’s stock is valued at $42.74 at 08:23 EST, under its 52-week high of $44.75 and way above its 52-week low of $34.86.

Royalty Pharma’s Moving Average

Royalty Pharma’s value is above its 50-day moving average of $41.56 and higher than its 200-day moving average of $40.20.

4. Sturm, Ruger & Company (RGR)

42.19% Payout Ratio

Together with its affiliates, Sturm, Ruger & Company, Inc. designs, manufactures, sells and markets firearms in the United States under the Ruger trademark.

Volume

Today’s last reported volume for Sturm, Ruger & Company is 88302, 34.85% below its average volume of 135550.

As claimed by Morningstar, Inc., the next dividend payment is on May 12, 2022, the estimated forward annual dividend rate is 3.33 and the estimated forward annual dividend yield is 5.08%.

Sturm, Ruger & Company’s sales growth this year is anticipated to be negative 16.5% and a negative 5.8% for next year.

Year-on-year quarterly revenue growth declined by 0.7%, now sitting on 730.74M for the twelve trailing months.

Sturm, Ruger & Company’s sales growth is negative 21.8% for the current quarter and negative 16.8% for the next. The company’s growth estimates for the current quarter and the next is negative 40.4% and negative -31.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.62%.

Volatility

Sturm, Ruger & Company’s last day, week, and month’s current intraday variation average was 0.54%, 1.24%, and 1.51%, respectively.

Sturm, Ruger & Company’s highest amplitude of average volatility was 1.67% (day), 2.51% (last week), and 2.92% (last month), respectively.

Sturm, Ruger & Company’s Stock Yearly Top and Bottom Value

Sturm, Ruger & Company’s stock is valued at $63.46 at 08:23 EST, way under its 52-week high of $84.12 and higher than its 52-week low of $60.61.

Sturm, Ruger & Company’s Moving Average

Sturm, Ruger & Company’s value is below its 50-day moving average of $64.62 and below its 200-day moving average of $69.06.

5. PNC Financial Services Group (PNC)

35.93% Payout Ratio

PNC Financial Group, Inc. is a United States-based diversified financial service company.

Volume

Today’s last reported volume for PNC Financial Services Group is 919903, 56.2% below its average volume of 2100590.

As maintained by Morningstar, Inc., the next dividend payment is on Oct 13, 2021, the estimated forward annual dividend rate is 5 and the estimated forward annual dividend yield is 2.44%.

PNC Financial Services Group’s sales growth this year is anticipated to be 12.7% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 27.7%, now sitting on 19B for the twelve trailing months.

PNC Financial Services Group’s sales growth is 17.9% for the current quarter and 21.1% for the next. The company’s growth estimates for the present quarter and the next is negative 2.1% and 7.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.72%.

Volatility

PNC Financial Services Group’s last day, week, and month’s current intraday variation average was 0.07%, 0.79%, and 0.89%, respectively.

PNC Financial Services Group’s highest amplitude of average volatility was 2.33% (day), 2.15% (last week), and 2.07% (last month), respectively.

PNC Financial Services Group’s Stock Yearly Top and Bottom Value

PNC Financial Services Group’s stock is valued at $165.95 at 08:23 EST, way below its 52-week high of $217.60 and way higher than its 52-week low of $141.03.

PNC Financial Services Group’s Moving Average

PNC Financial Services Group’s value is way under its 50-day moving average of $204.85 and way under its 200-day moving average of $190.99.

6. Nuveen S&P 500 Buy (BXMX)

35.83% Payout Ratio

Nuveen S&P500 Buy-Write income Fund, a closed-ended, equity-indexed mutual fund, was launched by Nuveen Investments, Inc. The fund is managed by Nuveen Fund Advisors LLC, and Gateway Investment Advisers, LLC.

Volume

Today’s last reported volume for Nuveen S&P 500 Buy is 86800, 60.02% below its average volume of 217162.

According to Morningstar, Inc., the next dividend payment is on Mar 13, 2022, the estimated forward annual dividend rate is 0.95 and the estimated forward annual dividend yield is 7.11%.

Year-on-year quarterly revenue growth declined by 28.7%, now sitting on 18.25M for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.49%.

Volatility

Nuveen S&P 500 Buy’s last day, week, and month’s current intraday variation average was 0.99%, 1.18%, and 0.88%, respectively.

Nuveen S&P 500 Buy’s highest amplitude of average volatility was 1.83% (day), 1.76% (last week), and 1.64% (last month), respectively.

Nuveen S&P 500 Buy’s Stock Yearly Top and Bottom Value

Nuveen S&P 500 Buy’s stock is valued at $13.15 at 08:24 EST, way under its 52-week high of $15.22 and above its 52-week low of $12.02.

Nuveen S&P 500 Buy’s Moving Average

Nuveen S&P 500 Buy’s worth is higher than its 50-day moving average of $13.04 and below its 200-day moving average of $13.99.

LEAVE A REPLY

Please enter your comment!
Please enter your name here